Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Africa has about 25.9 million (65%) of the global burden with Nigeria contributing about 1.9 million making it the fourth ...

Loopworm is ramping up production at a facility in Bangalore capable of churning out 6,000t of silkworm and black soldier fly ...

Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best Android antivirus apps go beyond finding and removing the latest malware to ...

US pharma major GSK yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant ...

An effective malware removal tool is essential to deal with today's threat landscape. According to computer science researcher Aviel D. Rubin, "People's computers are not getting more secure.

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using ...